CytomX Therapeutics, Inc. - CTMX

Insiders (Form 4) · last 180 days · showing up to 200 transactions · Form 144 is shown in the SEC filings tab · Updating…
Visible: 0
Transaction codes: P = Open-market purchase · S = Open-market sale · A = Grant/award · M = Exercise/conversion of derivative · G = Gift · F = Tax withholding · J = Other · A/D: A = Acquired (buy/receive) · D = Disposed (sell/give)
Filed Owner Title Code A/D Shares Price Value Shares after SEC
Mar 19, 2026 SVP, Chief Scientific Officer S D 31,492.0 6.423 202,273.12 300,760.0 View
Mar 19, 2026 CEO S D 118,969.0 6.423 764,137.89 1,078,922.0 View
Mar 19, 2026 Chief Medical Officer S D 21,279.0 6.423 136,675.02 189,446.0 View
Mar 19, 2026 Chief Financial Officer S D 19,323.0 6.423 124,111.63 296,948.0 View
Feb 04, 2026 Chief Financial Officer A A 325,000.0 0.0 0.0 325,000.0 View
Feb 04, 2026 Chief Financial Officer A A 90,000.0 0.0 0.0 316,271.0 View
Feb 04, 2026 CEO A A 980,000.0 0.0 0.0 980,000.0 View
Feb 04, 2026 CEO A A 210,000.0 0.0 0.0 1,197,891.0 View
Feb 04, 2026 SVP, Chief Scientific Officer A A 250,000.0 0.0 0.0 250,000.0 View
Feb 04, 2026 SVP, Chief Scientific Officer A A 60,000.0 0.0 0.0 332,252.0 View
Feb 04, 2026 Chief Medical Officer A A 300,000.0 0.0 0.0 300,000.0 View
Feb 04, 2026 Chief Medical Officer A A 75,000.0 0.0 0.0 210,725.0 View
Feb 04, 2026 Chief Business Officer A A 50,000.0 0.0 0.0 50,000.0 View
Feb 04, 2026 Chief Business Officer A A 50,000.0 0.0 0.0 50,000.0 View
Feb 04, 2026 Chief Business Officer A A 20,000.0 0.0 0.0 20,000.0 View
Nov 10, 2025 CEO S D 101,793.0 4.5377 461,906.1 987,891.0 View
Oct 29, 2025 Chief Business Officer A A 650,000.0 0.0 0.0 650,000.0 View